iShares Trust - iShares Global Healthcare ETF Past Earnings Performance
Past criteria checks 1/6
iShares Trust - iShares Global Healthcare ETF's earnings have been declining at an average annual rate of -7.2%, while the Capital Markets industry saw earnings growing at 9.7% annually. Revenues have been growing at an average rate of 16% per year. iShares Trust - iShares Global Healthcare ETF's return on equity is 9.5%, and it has net margins of 522.9%.
Key information
-7.2%
Earnings growth rate
-11.2%
EPS growth rate
| Capital Markets Industry Growth | 10.3% |
| Revenue growth rate | 16.0% |
| Return on equity | 9.5% |
| Net Margin | 522.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How iShares Trust - iShares Global Healthcare ETF makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 72 | 375 | 17 | 0 |
| 30 Jun 23 | 69 | 131 | 16 | 0 |
| 31 Mar 23 | 67 | -113 | 16 | 0 |
| 31 Dec 22 | 63 | -227 | 15 | 0 |
| 30 Sep 22 | 60 | -340 | 14 | 0 |
| 30 Jun 22 | 57 | 39 | 14 | 0 |
| 31 Mar 22 | 55 | 418 | 13 | 0 |
| 31 Dec 21 | 52 | 426 | 12 | 0 |
| 30 Sep 21 | 49 | 433 | 12 | 0 |
| 30 Jun 21 | 46 | 486 | 11 | 0 |
| 31 Mar 21 | 43 | 540 | 10 | 0 |
| 31 Dec 20 | 41 | 451 | 10 | 0 |
| 30 Sep 20 | 39 | 362 | 10 | 0 |
| 30 Jun 20 | 40 | 189 | 9 | 0 |
| 31 Mar 20 | 41 | 16 | 9 | 0 |
| 31 Dec 19 | 41 | 6 | 9 | 0 |
| 30 Sep 19 | 40 | -3 | 9 | 0 |
| 30 Jun 19 | 38 | 104 | 9 | 0 |
| 31 Mar 19 | 35 | 211 | 8 | 0 |
| 31 Dec 18 | 33 | 216 | 8 | 0 |
| 30 Sep 18 | 31 | 221 | 8 | 0 |
| 30 Jun 18 | 31 | 181 | 8 | 0 |
| 31 Mar 18 | 30 | 142 | 7 | 0 |
| 31 Dec 17 | 30 | 164 | 7 | 0 |
| 30 Sep 17 | 30 | 185 | 7 | 0 |
| 30 Jun 17 | 30 | 155 | 7 | 0 |
| 31 Mar 17 | 30 | 125 | 7 | 0 |
| 31 Dec 16 | 31 | 109 | 7 | 0 |
| 30 Sep 16 | 32 | 92 | 8 | 0 |
| 30 Jun 16 | 32 | -21 | 8 | 0 |
| 31 Mar 16 | 32 | -135 | 8 | 0 |
| 31 Dec 15 | 30 | -63 | 8 | 0 |
| 30 Sep 15 | 29 | 9 | 7 | 0 |
| 30 Jun 15 | 27 | 126 | 7 | 0 |
| 31 Mar 15 | 25 | 242 | 6 | 0 |
| 31 Dec 14 | 24 | 239 | 6 | 0 |
| 30 Sep 14 | 22 | 235 | 5 | 0 |
| 30 Jun 14 | 21 | 222 | 5 | 0 |
| 31 Mar 14 | 20 | 209 | 4 | 0 |
| 31 Dec 13 | 18 | 184 | 4 | 0 |
| 30 Sep 13 | 17 | 159 | 3 | 0 |
| 30 Jun 13 | 16 | 147 | 3 | 0 |
Quality Earnings: IXJ has a large one-off gain of $319.0M impacting its last 12 months of financial results to 30th September, 2023.
Growing Profit Margin: IXJ became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: IXJ's earnings have declined by 7.2% per year over the past 5 years.
Accelerating Growth: IXJ has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: IXJ has become profitable in the last year, making it difficult to compare its past year earnings growth to the Capital Markets industry (3.3%).
Return on Equity
High ROE: IXJ's Return on Equity (9.5%) is considered low.